Industry News
Vic ethics committee will examine biotech
A voluntary code of ethics for the Victorian biotechnology industry was likely to be the first task of the State Government's new ethics advisory committee. [ + ]
Tasmania wary of former GM sites
Former GM crop field trial sites in Tasmania are under close scrutiny from the Tasmanian Department of Primary Industries, Water and Environment. [ + ]
New research casts doubt on adult cell research
A pair of papers published this week in Nature have cast doubts on the ability of adult cells to become stem cells, capable of forming any cell in the body. [ + ]
Biotech outshines in stocks review
Biotechnology emerged as the star performer in a Pricewaterhouse Coopers review of the life sciences sector. [ + ]
Plant centre will allow new research
Researchers have welcomed the establishment of a new Plant Culture Facility (PCF) at ANU's Research School of Biological Sciences (RSBS). [ + ]
Biotron sacrifices profits for R&D
Biotechnology licensing company Biotron (ASX:BIT) has sacrificed profits in favour of ramping up research and development expenditure into its cancer diagnostic and anti-HIV drug programs. [ + ]
Baker and Amersham establish proteomics system
A fully-automated proteomics system has been installed at Melbourne's Baker Medical Research Institute. [ + ]
Antisense reports loss in lead-up to MS trial
Australia's newest listed biotechnology company, Antisense Therapeutics (ASX:ANP), today recorded a first-half loss of $1.6 million as it prepares for a pre-clinical study of its multiple sclerosis therapy. [ + ]
Gradipore R&D, marketing push offset sales revenue increase
A 75 per cent boost in sales revenues at Sydney biological separations company Gradipore was offset by continued heavy commitments in R&D and international expansion in its half-year results, released today. [ + ]
Lander sees life sciences revolution
Eric Lander, one of the world's leading scientists on the forefront of genome research, kicked off the BioITWorld conference in Boston on Wednesday with an overview of the dramatic progress made in biology in the past few years as a result of the sequencing of the human genome, and how this new information is being applied to investigate and fight diseases. [ + ]
Proteome-based diagnostic has crop, human applications
A diagnostic tool for measuring damage to wheat within three minutes has been developed by Sydney-based biotechnology company Proteome Systems, in collaboration with C-Qentec Diagnostics, a subsidiary of Aventis Crop Science Pty Ltd. [ + ]
Queensland splurges on supercomputer
A $4 million supercomputer is the Queensland government's latest addition to its already impressive investment in the state's biotech infrastructure assets. [ + ]
IT integration key to fueling drug development
To streamline drug discovery and development in the face of mind-numbing amounts of data, the need for integration and interoperability among applications, databases, and hardware is greater than ever before, according to an array of speakers at the recent BioSilico 2002 conference. [ + ]
UNSW joins international Linux research effort
A team from the University of NSW is one of the members of a newly-formed international group set up to examine how the Linux operating system running on Hewlett-Packard servers can serve as a key platform for research. [ + ]
Singapore to build $13M life sciences supercomputer
Singapore's Nanyang Technological University (NTU) and Compaq Computer Corp are to jointly build the infrastructure for Singapore's new Bioinformatics Research Centre (BIRC). [ + ]
